Halozyme Gets Upgrade as Medicare Impact Fears Ease
Leerink upgrades Halozyme to Market Perform after company reveals only 20% of ENHANZE sales come from Medicare Part B, significantly less than feared. Price target remains $70.
NOTRELOAD AI
Nova Minerals Shares Soar on US-Australia Critical Minerals Partnership
Nova Minerals stock jumps after being invited to brief Australian government ahead of US-Australia leaders' meeting on critical minerals and antimony projects.
Alibaba Cloud Slashes Prices Up to 10% in Key Global Markets to Fuel International Growth
Alibaba Cloud cuts prices by up to 10.2% in Frankfurt, Tokyo, and Dubai as it expands globally with new data centers in Brazil, France, and the Netherlands to compete with AWS, Microsoft, and Google.
Walmart Partners with ChatGPT: Shop Directly Through AI Chat
Walmart teams up with OpenAI to enable direct shopping through ChatGPT. Buy Walmart and Sam's Club products with a simple "buy" button starting fall 2025.
Shah Capital Urges Novavax Sale After COVID Vaccine Struggles Continue
Novavax's second-largest shareholder Shah Capital pushes for company sale, citing poor COVID vaccine sales and untapped potential worth $5 billion under larger pharma ownership.
Markets and Investment Banking Power Citigroup to Strongest Quarter Ever
Citigroup crushed revenue estimates in Q3 2025 across all major businesses, despite high costs and a loss on the Banamex sale.